Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 3/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.50 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.48 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 7/20 | 0.48 |
| ▸ | DRD3 | P35462 | 5/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.45 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7879688 | 0.95 | FLT3 (0.60) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| Hydrochloric Acid SCHEMBL8628097 | 0.84 | FLT3 (0.47) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| Hydrochloric Acid SCHEMBL7879743 | 0.84 | FLT3 (0.47) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| SCHEMBL7881219 | 0.84 | PDGFRB (0.56) | FLT3HRH3PDGFRBPDGFRADRD2 | |
| SCHEMBL7877790 | 0.84 | FLT3 (0.43) | FLT3HRH3PDGFRBDRD2DRD3 | |
| SCHEMBL7879727 | 0.84 | FLT3 (0.48) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| Hydrochloric Acid SCHEMBL7881410 | 0.83 | SYK (0.48) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| SCHEMBL7877763 | 0.83 | FLT3 (0.61) | FLT3PDGFRBPDGFRADRD2DRD3 | |
| SCHEMBL7873204 | 0.82 | HRH3 (0.42) | FLT3HRH3DRD2DRD3CHEK2 | |
| SCHEMBL7880873 | 0.82 | RXFP1 (0.43) | FLT3HRH3DRD2DRD3KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0622356-B1 | Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange | SUMITOMO PHARMA (JP) | 1998-07-01 | — | — | EP | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0622356-A1 | Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1994-11-02 | — | — | EP | disclosed |